Document Detail

Experimental models of chronic lower extremity arterial occlusive disease: lessons for drug development.
MedLine Citation:
PMID:  9546914     Owner:  NLM     Status:  MEDLINE    
Peripheral vascular disease is the result of chronic vascular insufficiency. As the vascular insufficiency of the lower limbs progressively deteriorates, the condition progresses from intermittent claudication (pain upon exercise) to pain at rest and gangrene. In very severe cases amputation of the leg may be necessary. Whilst dieting, cessation of smoking and physical exercise all beneficially affect the progression of the disorder, the available drug therapy is of limited benefit. Very effective pharmacological agents capable of alleviating the symptoms of chronic peripheral vascular disease have not been developed. In order to mimic the vascular insufficiency of intermittent claudication, an animal model was developed in rats. This involves short-term and long-term 6-10 weeks ligation of the femoral artery of the rat. As demonstrated using measurements of hindlimb skeletal muscle, blood flow, pO2, metabolism and function, a model of intermittent claudication was produced. Using this model, the beneficial effects of physical training was demonstrated. Physical training induced an increase in blood flow and a greater capacity for aerobic metabolism in the partially ischaemic skeletal muscle. The effect of vasodilators has also been examined in this model; in contrast to agents such as Ca2+ antagonists, K+ channel openers appear to improve nutritional blood flow and metabolism in the afflicted skeletal muscle. This model can also be utilized to demonstrate the effects of haemorrheological interventions and of agents modulating muscle metabolism. However, additional effort is required to develop models for the evaluation of efficacy of antiatherothrombotic drugs.
C D Nicholson
Related Documents :
17558664 - Driver headway: how close is too close on a motorway?
9129604 - A comparative study of treadmill tests and heel raising exercise for peripheral arteria...
7369534 - Fibrositic myofascial pain in intermittent claudication: significance of trigger areas ...
6729674 - The effect of exercise upon cutaneous oxygen delivery in the extremities of patients wi...
16808134 - Comparison of injury rates between cadets with limb length inequalities and matched con...
25479564 - Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by inc...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Vascular medicine (London, England)     Volume:  1     ISSN:  1358-863X     ISO Abbreviation:  Vasc Med     Publication Date:  1996  
Date Detail:
Created Date:  1998-04-14     Completed Date:  1998-04-14     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9610930     Medline TA:  Vasc Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  43-9     Citation Subset:  IM    
NV Organon, Scientific Development Group, Oss, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arterial Occlusive Diseases / drug therapy*
Disease Models, Animal
Hindlimb / blood supply*
Muscle, Skeletal / blood supply,  metabolism
Physical Conditioning, Animal
Regional Blood Flow
Vasodilator Agents / therapeutic use
Reg. No./Substance:
0/Vasodilator Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Claudication as an 'orphan disease': rationale and goals of drug therapy for peripheral arterial dis...
Next Document:  Microvascular changes in arterial occlusive disease: target for pharmacotherapy.